UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 439

Sortiert nach

(055) Effect of Loop Electrosurgical Excision Procedure (LEEP) on Female Sexual Function

Journal of sexual medicine, 2023-06, Vol.20 (Supplement_3)

2023

Volltextzugriff (PDF)

Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials

Innovations in clinical neuroscience, 2024-01, Vol.21 (1-3), p.13-18

2024

Volltextzugriff (PDF)

Corrigendum to “Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study” [Schizophr. Res. 239 (2022) 83–91]

Schizophrenia research, 2022-08, Vol.246, p.258-259

2022

Volltextzugriff (PDF)

Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

Schizophrenia research, 2022-01, Vol.239, p.83-91

2022

Volltextzugriff (PDF)

Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2019-02, Vol.44 (3), p.598-605

2019

Volltextzugriff (PDF)

Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2019-02, Vol.44 (3), p.598

2019

Volltextzugriff (PDF)

Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells

Oncogene, 2009-07, Vol.28 (30), p.2697-2709

2009

Volltextzugriff (PDF)

Cariprazine in the treatment of schizophrenia: a proof-of-concept trial

International clinical psychopharmacology, 2016-03, Vol.31 (2), p.61

2016

Volltextzugriff (PDF)

AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study

Schizophrenia research, 2016-04, Vol.172 (1), p.152-157

2016

Volltextzugriff (PDF)

Positional Isotope Exchange in HX·(H2O) n (X = F, I) Clusters at Low Temperatures

The journal of physical chemistry. A, Molecules, spectroscopy, kinetics, environment, & general theory, 2016-09, Vol.120 (36), p.7213-7224

2016

Volltextzugriff (PDF)

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

Innovations in clinical neuroscience, 2021-01, Vol.18 (1-3), p.35-38

2021

Volltextzugriff (PDF)

Photophysics of Xanthene Dyes at High Concentrations in Solid Environments: Charge Transfer Assisted Triplet Formation

Photochemistry and photobiology, 2018-09, Vol.94 (5), p.865-874

2018

Volltextzugriff (PDF)

Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis

International journal of clinical practice (Esher), 2017-12, Vol.71 (12), p.e13037-n/a

2017

Volltextzugriff (PDF)

A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia

International clinical psychopharmacology, 2018-03, Vol.33 (2), p.79

2018

Volltextzugriff (PDF)

The selective neurokinin 3 antagonist AZD2624 does not improve symptoms or cognition in schizophrenia: a proof-of-principle study

Journal of clinical psychopharmacology, 2014-04, Vol.34 (2), p.199-204

2014

Volltextzugriff (PDF)

8944 Outcomes Among Patients Undergoing Gender-Affirming Hysterectomy from 2010-2020: A NSQIP Analysis

Journal of minimally invasive gynecology, 2022-11, Vol.29 (11), p.S159-S159

2022

Volltextzugriff (PDF)

Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies

Journal of clinical psychopharmacology, 2008-04, Vol.28 (2 Suppl 1), p.S4-S11

2008

Volltextzugriff (PDF)

Poster #S239 AZD8529, A POSITIVE ALLOSTERIC MODULATOR AT THE MGLUR2 RECEPTOR, DOES NOT IMPROVE SYMPTOMS IN SCHIZOPHRENIA: A PROOF OF PRINCIPLE STUDY

Schizophrenia research, 2014-04, Vol.153, p.S176-S176

2014

Volltextzugriff (PDF)

Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine

British journal of psychiatry, 1996-05, Vol.168 (5), p.571-579

1996

Volltextzugriff (PDF)

Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation

NPJ schizophrenia, 2020-11, Vol.6 (1), p.37-37, Article 37

2020

Volltextzugriff (PDF)

Dioxin and furan levels found in tampons

Journal of women's health (Larchmont, N.Y. 2002), 2005-05, Vol.14 (4), p.311

2005

Volltextzugriff (PDF)

Impact of COVID-19 Pandemic on Psychiatric Patients at Clinical Trial Sites

Innovations in clinical neuroscience, 2022-10, Vol.19 (10-12), p.24-28

2022

Volltextzugriff (PDF)

Suicidology: A Look Backward and Ahead

Suicide & life-threatening behavior, 1996, Vol.26 (1), p.1-7

Litman, Robert E.

1996

Volltextzugriff (PDF)

Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia

Schizophrenia research, 1994-05, Vol.12 (2), p.107-120

1994

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2009-04, Vol.34 (5), p.1322-1329

2009

Volltextzugriff (PDF)

1 – 25 von 439

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(337)
Mit Volltextzugriff
(315)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(244)
Life Sciences & Biomedicine
(218)
Humans
(204)
Female
(107)
Biological And Medical Sciences
(91)
Medical Sciences
(81)
Male
(75)
Adult
(68)
Middle Aged
(59)
Psychiatry
(50)
Animals
(39)
Pharmacology. Drug Treatments
(35)
Suicide
(31)
Social Sciences
(30)
Aged
(28)
Psychology. Psychoanalysis. Psychiatry
(28)
Biochemistry & Molecular Biology
(25)
Treatment Outcome
(25)
Psychology
(23)
Urinary Incontinence, Stress - Surgery
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

(055) Effect of Loop Electrosurgical Excision Procedure (LEEP) on Female Sexual Function

Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials

Corrigendum to “Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study” [Schizophr. Res. 239 (2022) 83–91]

Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells

Cariprazine in the treatment of schizophrenia: a proof-of-concept trial

AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study

Positional Isotope Exchange in HX·(H2O) n (X = F, I) Clusters at Low Temperatures

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

Photophysics of Xanthene Dyes at High Concentrations in Solid Environments: Charge Transfer Assisted Triplet Formation

Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis

A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia

The selective neurokinin 3 antagonist AZD2624 does not improve symptoms or cognition in schizophrenia: a proof-of-principle study

8944 Outcomes Among Patients Undergoing Gender-Affirming Hysterectomy from 2010-2020: A NSQIP Analysis

Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies

Poster #S239 AZD8529, A POSITIVE ALLOSTERIC MODULATOR AT THE MGLUR2 RECEPTOR, DOES NOT IMPROVE SYMPTOMS IN SCHIZOPHRENIA: A PROOF OF PRINCIPLE STUDY

Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine

Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation

Dioxin and furan levels found in tampons

Impact of COVID-19 Pandemic on Psychiatric Patients at Clinical Trial Sites

Suicidology: A Look Backward and Ahead

Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia

A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia

Suchergebnisse filtern